JAMDA:如何使大家更好地接受髋部保护器?

2015-03-28 MedSci MedSci原创

背景:对高危跌倒者而言,在长期护理所需的设备中,髋关节保护器具是减少髋部骨折的一个有吸引力的设备和工具。然而,对它们的临床价值,临床研究产生相互矛盾的结果。这主要是由于大家普遍不了解和不接受,但使用者又坚持使用并肯定它的价值所致。因此,我们急需解决这些问题:找到髋部保护器面向大众过程中存在的潜在障碍,生产商如何让大众接受髋部保护器的同时又能够让之前的使用者继续坚持使用。目的:这篇系统性综述的目的在

背景:对高危跌倒者而言,在长期护理所需的设备中,髋关节保护器具是减少髋部骨折的一个有吸引力的设备和工具。然而,对它们的临床价值,临床研究产生相互矛盾的结果。这主要是由于大家普遍不了解和不接受,但使用者又坚持使用并肯定它的价值所致。因此,我们急需解决这些问题:找到髋部保护器面向大众过程中存在的潜在障碍,生产商如何让大众接受髋部保护器的同时又能够让之前的使用者继续坚持使用。

目的:这篇系统性综述的目的在于综合各种能获得的且有效的研究证据来确定在老年人生活所使用的长期护理设施中,影响他们接受和使用髋部保护器的相关因素。

研究方式:我们利用关键字搜索的方式找到发表在2000-2013年间所有定量、定性或多方式混合的英文研究设计。两个独立的审稿员分别搜寻每篇文章的内容是否符合我们的标准,若对文章存在争议,则第三个审稿员处理存在的差异。

结果:通过筛选,有28篇文章符合我们的取材标准。通过我们研究分析,将存在的所有促进因素和障碍因素划分为4个社会生态学因素水平:生产商家(如设施是否有质量保证、生产人员是否紧缺);护理者(如保护具的有效性宣传是否到位、有无宣传相反言论);使用保护具的患者(如是否存在跌倒和相关损伤的高危因素、有无急性病发生);产品(如外包装是否给人以舒适感或不舒适感)。

结论:这篇文章为生产商、骨科医生、护士在思考改善髋关节保护具性能及提高大众依从性方面有何策略提供了更深的认识和更长远的见解。此外,研究人员可以利用这些信息设计临床试验来更好地使髋关节保护具面向大众,并提高大众患者的依从性。

原始出处

Alexandra M.B. Korall, BSca, †, Fabio Feldman, PhDa, b, , †, , Vicky J. Scott, RN, PhDc.Facilitators of and Barriers to Hip Protector Acceptance and Adherence in Long-term Care Facilities: A Systematic Review .JAMDA.2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=36600, encodeId=1d503660007, content=不错,很好的文章!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Wed Sep 09 15:19:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20870, encodeId=2259208e006, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:38:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943513, encodeId=17e019435132a, content=<a href='/topic/show?id=daad11404a3' target=_blank style='color:#2F92EE;'>#MDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11404, encryptionId=daad11404a3, topicName=MDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Sep 30 13:15:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315973, encodeId=ab4513159e359, content=<a href='/topic/show?id=fa2e24053f' target=_blank style='color:#2F92EE;'>#AMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2405, encryptionId=fa2e24053f, topicName=AMD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec53439, createdName=zhty5337, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408467, encodeId=9eed140846e2f, content=<a href='/topic/show?id=92021020e814' target=_blank style='color:#2F92EE;'>#髋部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102078, encryptionId=92021020e814, topicName=髋部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293f2750231, createdName=liuquan, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2015-09-09 Bobby7868

    不错,很好的文章!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=36600, encodeId=1d503660007, content=不错,很好的文章!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Wed Sep 09 15:19:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20870, encodeId=2259208e006, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:38:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943513, encodeId=17e019435132a, content=<a href='/topic/show?id=daad11404a3' target=_blank style='color:#2F92EE;'>#MDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11404, encryptionId=daad11404a3, topicName=MDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Sep 30 13:15:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315973, encodeId=ab4513159e359, content=<a href='/topic/show?id=fa2e24053f' target=_blank style='color:#2F92EE;'>#AMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2405, encryptionId=fa2e24053f, topicName=AMD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec53439, createdName=zhty5337, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408467, encodeId=9eed140846e2f, content=<a href='/topic/show?id=92021020e814' target=_blank style='color:#2F92EE;'>#髋部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102078, encryptionId=92021020e814, topicName=髋部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293f2750231, createdName=liuquan, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2015-04-12 x35042875

    患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=36600, encodeId=1d503660007, content=不错,很好的文章!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Wed Sep 09 15:19:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20870, encodeId=2259208e006, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:38:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943513, encodeId=17e019435132a, content=<a href='/topic/show?id=daad11404a3' target=_blank style='color:#2F92EE;'>#MDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11404, encryptionId=daad11404a3, topicName=MDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Sep 30 13:15:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315973, encodeId=ab4513159e359, content=<a href='/topic/show?id=fa2e24053f' target=_blank style='color:#2F92EE;'>#AMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2405, encryptionId=fa2e24053f, topicName=AMD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec53439, createdName=zhty5337, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408467, encodeId=9eed140846e2f, content=<a href='/topic/show?id=92021020e814' target=_blank style='color:#2F92EE;'>#髋部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102078, encryptionId=92021020e814, topicName=髋部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293f2750231, createdName=liuquan, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2015-09-30 wetgdt
  4. [GetPortalCommentsPageByObjectIdResponse(id=36600, encodeId=1d503660007, content=不错,很好的文章!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Wed Sep 09 15:19:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20870, encodeId=2259208e006, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:38:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943513, encodeId=17e019435132a, content=<a href='/topic/show?id=daad11404a3' target=_blank style='color:#2F92EE;'>#MDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11404, encryptionId=daad11404a3, topicName=MDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Sep 30 13:15:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315973, encodeId=ab4513159e359, content=<a href='/topic/show?id=fa2e24053f' target=_blank style='color:#2F92EE;'>#AMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2405, encryptionId=fa2e24053f, topicName=AMD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec53439, createdName=zhty5337, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408467, encodeId=9eed140846e2f, content=<a href='/topic/show?id=92021020e814' target=_blank style='color:#2F92EE;'>#髋部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102078, encryptionId=92021020e814, topicName=髋部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293f2750231, createdName=liuquan, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2015-03-30 zhty5337
  5. [GetPortalCommentsPageByObjectIdResponse(id=36600, encodeId=1d503660007, content=不错,很好的文章!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75bb1617091, createdName=Bobby7868, createdTime=Wed Sep 09 15:19:00 CST 2015, time=2015-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20870, encodeId=2259208e006, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:38:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943513, encodeId=17e019435132a, content=<a href='/topic/show?id=daad11404a3' target=_blank style='color:#2F92EE;'>#MDA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11404, encryptionId=daad11404a3, topicName=MDA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Wed Sep 30 13:15:00 CST 2015, time=2015-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315973, encodeId=ab4513159e359, content=<a href='/topic/show?id=fa2e24053f' target=_blank style='color:#2F92EE;'>#AMD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2405, encryptionId=fa2e24053f, topicName=AMD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec53439, createdName=zhty5337, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408467, encodeId=9eed140846e2f, content=<a href='/topic/show?id=92021020e814' target=_blank style='color:#2F92EE;'>#髋部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102078, encryptionId=92021020e814, topicName=髋部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=293f2750231, createdName=liuquan, createdTime=Mon Mar 30 06:15:00 CST 2015, time=2015-03-30, status=1, ipAttribution=)]
    2015-03-30 liuquan

相关资讯

NEJM:食管腺癌临床诊疗综述

在北美和欧洲食管腺癌是最主要的食管癌类型。胃食管返流性疾病(GERD)和肥胖是主要危险因素。目前已经知道的癌前损害是Barrett食管,通过内镜检查发现,发现后按照癌前损害进行治疗和监控。亚洲、非洲、南美和北美的黑人食管鳞癌是食管癌主要类型。酒精和烟草是主要危险因素,食管鳞状异型增生是主要癌前损害。过去的10年里,尽管食管癌5年生存率仍然很差,但已有改善,早期和局部进展期食管癌病人长期生存可能

饶毅:学霸怎样读文献

通过科学研究的刊物读原始论文和综述等文献,首先是学习的一步,是学术成长的必需;其后成为研究人员的日常工作的一部分,所谓活到老学到老对自然科学研究者来说不是例外而是常规,停止读文献之日基本是退出科学前沿之时。 读文献时,可以经常想其他人的文章与自己目前的研究能否有关系,也可以想文献对自己以后的方向的影响。经常这么要求自己可能从文献得到帮助,不过多数时候阅读文献并不一定马上有用,

江明教授疾呼狠杀研究生滥发综述之风

题记:研究生广泛阅读文献本是件好事,但是以写所谓的高引用综述为目标读文献则完全背离科学研究和人才培养的基本原则。复旦大学江明院士对这种新型的科研浮躁深感忧虑,撰写了以下文字,在几个微信群里发布了。江老师未在科学网上注册,为此,按江老师嘱托,将他的原文全文转帖在这里。 科研浮躁一范本 人人都在说当今做科研浮躁,可哪些是浮躁,浮躁到什么程度还是众说纷云。近见网上流传湖南大学环境学院4位

湖南大学介绍研究生发表"综述文章"经验受广泛质疑

学生该不该发表综述?有广泛的争议,湖南大学将几位硕士生与博士发表高影响因子的综述经验公之于众,一则令人羡慕,小小年纪就能发表如此高分的论文(虽然是综述),另一则言外之意,鼓励研究生写综述,综述属于易发表,又不需要做研究的方法,一举两得,何乐不为?但换言之,综述在国际上看看是一些牛人,国内研究生也能干同样的活,个中意味如何?江明教授言辞激烈反对这一现象,不应鼓励研究生写综述(见:江明教授疾呼狠杀研究

马臻:研究生写综述,别逞能

近日收到读者来信:“您之前的博文曾经提到过,在美国读博时,您利用化学系搬家的几个月写了一篇很长的综述,引文有1000多篇。我很想了解这样的综述是怎样写出来的,怎么会去写这么长的综述。我是生物学专业的,还有写综述时要注意些什么。”具体的回复,会私下进行。从读者来信,我想到一个话题:研究生写综述,别逞能。并非针对这封读者来信,而是这封来信提醒了我进行思考。在这个纷繁芜杂的世界,充满了各种机会。可是很多

导师心目中的理想论文:克雷斯威尔五步文献综述法

每年答辩季节都要评审学位论文,每年自己学生的论文也都反复修改。但无论怎么细心,错误总还是有。遗憾依旧在,只是换新人。 那么什么样的学位论文才是好论文呢?实际上大家也很明白,心里也都清楚。网上每年公布的国家优秀博士学位论文,科学院的优秀博士学位论文等,都是些典范(尽管也有些被指出有一些缺点,总体看应该是没有大问题的)。有些海归回来的教授们的论文自然也是优秀的。样板处处有。 作为交流吧,我还是